Dendritic cell vaccine (DanDrit Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDendritic cell vaccine (DanDrit Biotech)

Drug Alias NameMCV (DanDrit Biotech)树突细胞疫苗 - DanDrit Biotech树突状细胞疫苗 - DanDrit BiotechMelCancerVac

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesDandrit Biotech A/S

China Registration ClassN/A

Develop Information

Active CompaniesDandrit Biotech A/S

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A